(1.1mm), set 1 array, 75 cases, 150 samples Endometrial

ab178149 – Endometrial cancer tissue array, 75 cases, 150 samples (1.1mm), set 1

Instructions for UseFor IHC or ISH based protein or RNA tissue profiling in various endometrium cancers.

This product is for research use only and is not intended for diagnostic use.

Product Overview:ab178149 is an endometrial cancer tissue array, set 1, non-overlapping with ab178150, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.

Case: 75Core: 150Format: 10 rows x 15 columnsSize: 1.1mmThickness: 4µm

All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. There may be >5% tissue core losses for a slide. But retention rate should be >90%.

Notes for use:Bake the slides at 60°C for 30 minutes before use. If antigen retrieval is needed, it is always a good idea to start with a protocol with weak to mild strength.For hints and tips on Immunohistochemistry as well as other techniques please visit www.abcam.com/protocols.Keep up to date on Abcam events and conferences on Facebook & Twitter.

1

http://www.abcam.com/protocols

Array Position Age Sex Anatomic

Site Nature Pathology Grade Stage (TNM)

A01 52 F Uterus, endometrium Normal Normal



A04 53 F Uterus, endometrium Hyperplasia Atypical

hyperplasia

A05 63 F Uterus, endometrium Hyperplasia Atypical

hyperplasia

A06 44 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

A07 62 F Uterus, endometrium Malignant Adenocarcinoma II T2N1M0

A08 56 F Uterus, endometrium Malignant Adenosquamous

carcinoma T1N0M0

A09 56 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

A10 56 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0



A13 51 F Uterus, endometrium Malignant Adenocarcinoma I~II T2N0M0


A15 43 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0

B01 52 F Uterus, endometrium Normal Normal



B04 53 F Uterus, endometrium Hyperplasia Atypical

hyperplasia

B05 63 F Uterus, endometrium Hyperplasia Atypical

hyperplasia

B06 44 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

B07 62 F Uterus, endometrium Malignant Adenocarcinoma II T2N1M0

B08 56 F Uterus, endometrium Malignant Adenosquamous

carcinoma T1N0M0

2



B09 56 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

B10 56 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0



B13 51 F Uterus, endometrium Malignant Adenocarcinoma I~II T2N0M0


B15 43 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0

C01 46 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

C02 78 F Uterus, endometrium Malignant Adenocarcinoma II T2N1M0

C03 53 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0

C04 49 F Uterus, endometrium Malignant Adenocarcinoma I T3N1M0

C05 47 F Uterus, endometrium Malignant Squamous cell

carcinoma I T1N0M0

C06 55 F Uterus, endometrium Malignant Adenocarcinoma II~III T2N1M0










D01 46 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

3



D02 78 F Uterus, endometrium Malignant Adenocarcinoma II T2N1M0

D03 53 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0

D04 49 F Uterus, endometrium Malignant Adenocarcinoma I T3N1M0

D05 47 F Uterus, endometrium Malignant Squamous cell

carcinoma I T1N0M0

D06 55 F Uterus, endometrium Malignant Adenocarcinoma II~III T2N1M0










E01 48 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

E02 53 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0





E07 70 F Uterus, endometrium Malignant Adenosquamous

carcinoma III T1N0M0



carcinoma T1N0M0

4



E10 53 F Uterus, endometrium Malignant Adenocarcinoma II~III T1N1M0




E13 52 F Uterus, endometrium Malignant Adenocarcinoma II~III T1N0M0


E15 50 F Uterus, endometrium Malignant Adenocarcinoma III T1N1M0

F01 48 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

F02 53 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0





F07 70 F Uterus, endometrium Malignant Adenosquamous




carcinoma T1N0M0

F10 53 F Uterus, endometrium Malignant Adenocarcinoma II~III T1N1M0




F13 52 F Uterus, endometrium Malignant Adenocarcinoma II~III T1N0M0


F15 50 F Uterus, endometrium Malignant Adenocarcinoma III T1N1M0

G01 55 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

G02 53 F Uterus, endometrium Malignant Undifferentiated

carcinoma T3N0M0

5



G03 50 F Uterus, endometrium Malignant Endometrial

stromal sarcoma T1N0M0

G04 60 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0





G09 36 F Uterus, endometrium Malignant Undifferentiated

carcinoma T1N0M0



G12 51 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0


G14 39 F Uterus, endometrium Malignant Adenocarcinoma I T2N0M0

G15 44 F Uterus, endometrium Malignant Stromal

sarcoma

H01 55 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

H02 53 F Uterus, endometrium Malignant Undifferentiated

carcinoma T3N0M0

H03 50 F Uterus, endometrium Malignant Endometrial

stromal sarcoma T1N0M0

H04 60 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0


carcinoma I~II T1N0M0





carcinoma T1N0M0


6




H12 51 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0


H14 39 F Uterus, endometrium Malignant Adenocarcinoma I T2N0M0

H15 44 F Uterus, endometrium Malignant Stromal

sarcoma

I01 46 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

I02 43 F Uterus, endometrium Malignant Adenocarcinoma II~III T2N0M0



I05 51 F Uterus, endometrium Malignant Undifferentiated

carcinoma T1N1M0

I06 42 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0


I08 66 F Uterus, endometrium Malignant Undifferentiated

carcinoma T1N0M0


I10 54 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

I11 33 F Uterus, endometrium Malignant Adenocarcinoma I~II T2N0M0

I12 60 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0

I13 58 F Uterus, endometrium Malignant Squamous cell

carcinoma II~III T1N0M0



J01 46 F Uterus, endometrium Malignant Adenocarcinoma III T1N0M0

J02 43 F Uterus, endometrium Malignant Adenocarcinoma II~III T2N0M0


7




J05 51 F Uterus, endometrium Malignant Undifferentiated

carcinoma T1N1M0

J06 42 F Uterus, endometrium Malignant Adenocarcinoma I T1N0M0


J08 66 F Uterus, endometrium Malignant Undifferentiated

carcinoma T1N0M0


J10 54 F Uterus, endometrium Malignant Adenocarcinoma II T1N0M0

J11 33 F Uterus, endometrium Malignant Adenocarcinoma I~II T2N0M0

J12 60 F Uterus, endometrium Malignant Adenocarcinoma I~II T1N0M0

J13 58 F Uterus, endometrium Malignant Squamous cell

carcinoma II~III T1N0M0



8

9

10

UK, EU and ROWEmail: [email protected] | Tel: +44-(0)1223-696000

AustriaEmail: [email protected] | Tel: 019-288-259

FranceEmail: [email protected] | Tel: 01-46-94-62-96 GermanyEmail: [email protected] | Tel: 030-896-779-154 SpainEmail: [email protected] | Tel: 911-146-554 SwitzerlandEmail: [email protected] Tel (Deutsch): 0435-016-424 | Tel (Français): 0615-000-530

US and Latin AmericaEmail: [email protected] | Tel: 888-77-ABCAM (22226)

CanadaEmail: [email protected] | Tel: 877-749-8807

China and Asia Pacific Email: [email protected] | Tel: 108008523689 (中國聯通) JapanEmail: [email protected] | Tel: +81-(0)3-6231-0940

www.abcam.com | www.abcam.cn | www.abcam.co.jp

11Copyright © 2013 Abcam, All Rights Reserved. The Abcam logo is a registered trademark. All information / detail is correct at time of going to print.

Documents

(1.1mm), set 1 array, 75 cases, 150 samples Endometrial